Official Title
COVID-19 Post-Vaccination Observation on Immune Exhaustion
Brief Summary
The study started after the second COVID-19 vaccination of the participant with bloodspots appearing on the skin with severe arthritis. The study continued to the third-dosefull vaccination of the participant with the recombined COVID-19 vaccination andafterwards. The study completed until intervention.
Detailed Description
Not Provided
Active, not recruiting
Immune System Diseases
COVID-19 Vaccine Adverse Reaction
Immune System Disorder
Eligibility Criteria
All COVID-19 vaccinated are eligible for inclusion.
Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 70 Years
Countries
China
Locations
Residential Address
Chongqing, Chongqing, China
Not Provided
Yang I. Pachankis, PhD
NCT Number
MeSH Terms
COVID-19
Immune System Diseases